Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Image INDIANAPOLIS- Eli Lilly and Company (NYSE: LLY) today announced Zepbound (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand
Unlock by turning the lock ring
This significant price reduction can save patients between $8,000 and $10,000 annually, making this life-changing medication accessible to those who previously couldn't afford or access it
We may review order details when information needs clarification before the medicine is supplied through licensed pharmacy channels
Its function is to generate the nail plate through the proliferation of epidermal cells
US$ 27.49
US$ 27.74
US$ 21.58
US$ 28.34
US$ 20.90
US$ 25.50
US$ 23.80
US$ 23.31
US$ 28.72
US$ 22.24
